Eyetech Pharmaceuticals' P2P Acquisition

Eyetech Pharmaceuticals raised a round of funding on November 21, 2005. Investors include OSI Pharmaceuticals.

Eyetech Pharmaceuticals was founded to discover and develop new drugs to reduce and prevent serious vision loss caused by eye disease. Eyetech's lead product, EYE001, addresses the two leading causes …

Articles about Eyetech Pharmaceuticals' P2P Acquisition: